Skip to main content

Table 1 Baseline characteristics

From: Application and comparison of different implanted ports in malignant tumor patients

Variable Upper vein group Jugular vein group Subclavian vein group
Patients 107 70 167
Age (years) 54.4 ± 12.3 53.8 ± 13.0 53.0 ± 13.3
Sex
 Male 64 (59.8) 41 (58.6) 104 (62.3)
 Female 43 (40.2) 29 (41.4) 63 (37.7)
Primary tumor
 Colon cancer 33 (30.8) 31 (44.3) 66 (39.5)
 Rectal cancer 52 (48.6) 31 (44.3) 84 (50.3)
 Gastric cancer 12 (11.2) 7 (10.0) 13 (7.8)
 Pancreatic cancer 2 (1.9) 1 (1.4) 0 (0)
 Small intestinal carcinoma 1 (0.9) 0 (0) 0 (0)
 Esophageal cancer 1 (0.9) 0 (0) 3 (1.8)
 Bile duct carcinoma 1 (0.9) 0 (0) 0 (0)
 Hepatic carcinoma 1 (0.9) 0 (0) 0 (0)
 Others 4 (3.7) 0 (0) 1 (0.6)
Follow-up duration (days) 257.6 ± 134.1 307.9 ± 134.3 253.4 ± 152.8
  1. Data in parenthesis is a percentage